⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity USA - English USA - English
prnewswire.com
VEEV
BMY
MRNA
NVO
OTK
CRNX
Phoenix NP Expands Access to FDA-Approved Weight Loss Medications Across Arizona
globenewswire.com
NVO
LLY
Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund USA - English USA - Deutsch USA - español Japan - Japanese USA - Français USA - English
prnewswire.com
NVO
ABT
RHHBY
MDT
Hedia nomme un nouveau directeur général : Rasmus Kofoed succède à Lars Christian Lund USA - Français Japan - Japanese USA - English USA - Deutsch USA - español USA - English
prnewswire.com
MDT
ABT
RHHBY
NVO
Hedia nombra nuevo consejero delegado: Rasmus Kofoed sucederá a Lars Christian Lund USA - español USA - English USA - English USA - Français USA - Deutsch Japan - Japanese
prnewswire.com
NVO
ABT
RHHBY
MDT
7MM Metabolic Dysfunction-Associated Steatohepatitis Drug Analysis and Forecast Report 2022-2032: Growth Driven by GLP-1RA Launches Such as Semaglutide and Rising Adoption of Non-Invasive Diagnostics
globenewswire.com
MRVL
NVO
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
prnewswire.com
NVO
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
Zealthy Under Review: The 2025 Doctor-Led GLP-1 Weight Loss Program That's Changing the Industry
accessnewswire.com
NVO
LLY
Team Novo Nordisk confirms ten rider Development Team for 2026
prnewswire.com
NVO